+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Respiratory Drugs Market Research Reports

IgE Receptor Antagonists - Pipeline Insight, 2025 - Product Thumbnail Image

IgE Receptor Antagonists - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Integrin Alpha4beta1 Antagonists - Pipeline Insight, 2025 - Product Thumbnail Image

Integrin Alpha4beta1 Antagonists - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Ventilator Associated Pneumonia (VAP) - Pipeline Insight, 2025 - Product Thumbnail Image

Ventilator Associated Pneumonia (VAP) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
Leukotriene D4 Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

Leukotriene D4 Antagonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Leukotriene Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

Leukotriene Antagonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Tuberculosis - Pipeline Insight, 2025 - Product Thumbnail Image

Tuberculosis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Nosocomial Pneumonia - Pipeline Insight, 2025 - Product Thumbnail Image

Nosocomial Pneumonia - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
Epithelial Sodium Channel (ENaC) Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Epithelial Sodium Channel (ENaC) Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Bronchiolitis Obliterans Syndrome - Pipeline Insight, 2025 - Product Thumbnail Image

Bronchiolitis Obliterans Syndrome - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
ARDS - Pipeline Insight, 2025 - Product Thumbnail Image

ARDS - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Pneumococcal Pneumonia - Pipeline Insight, 2025 - Product Thumbnail Image

Pneumococcal Pneumonia - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Interstitial Lung Disease - Pipeline Insight, 2025 - Product Thumbnail Image

Interstitial Lung Disease - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 200 Pages
  • Global
From
Severe Asthma - Pipeline Insight, 2025 - Product Thumbnail Image

Severe Asthma - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 180 Pages
  • Global
From
Eosinophilic Asthma - Pipeline Insight, 2025 - Product Thumbnail Image

Eosinophilic Asthma - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Asthma - Pipeline Insight, 2025 - Product Thumbnail Image

Asthma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 240 Pages
  • Global
From
Autoimmune Pulmonary Alveolar Proteinosis (aPAP) - Pipeline Insight, 2025 - Product Thumbnail Image

Autoimmune Pulmonary Alveolar Proteinosis (aPAP) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Pulmonary Fibrosis - Pipeline Insight, 2025 - Product Thumbnail Image

Pulmonary Fibrosis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 280 Pages
  • Global
From
Pulmonary Sarcoidosis - Pipeline Insight, 2025 - Product Thumbnail Image

Pulmonary Sarcoidosis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 50 Pages
  • Global
From
Loading Indicator

The Respiratory Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat respiratory diseases. These drugs are used to treat a variety of conditions, including asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis. Commonly prescribed respiratory drugs include bronchodilators, corticosteroids, and antibiotics. The Respiratory Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Companies in the market include GlaxoSmithKline, AstraZeneca, Merck & Co., Novartis, and Boehringer Ingelheim. These companies are constantly researching and developing new drugs to treat respiratory diseases, as well as improving existing treatments. Show Less Read more